Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Generic Lopinavir/Ritonavir in Thai HIV-infected Pregnant Women
NCT00621166Phase 2Completed
- Sponsor
- HIV-NAT
- Start
- Jun 2008
- Primary completion
- Dec 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, open-label trial of lopinavir and ritonavir in human immunodeficiency virus infection (HIV), sponsored by HIV-NAT. Primary endpoint: Pharmacokinetic profile of generic lopinavir/ritonavir at 1 year. Started Jun 2008; status: completed.
02
Drugs
lopinavirritonavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00621166.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00621166.